Stem cells aim to free kidney patients from lifelong pills
NCT ID NCT03504241
First seen Feb 14, 2026 · Last updated May 23, 2026 · Updated 13 times
Summary
This early-stage study tested a new approach to help kidney transplant recipients stop their daily anti-rejection drugs. Eight adults received donor stem cells along with a special drug combination, with the goal of safely weaning them off all immunosuppression. The main focus was on safety and whether the body would accept the new kidney without long-term medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke University Health System
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.